Figure 1.
Trends in (A) B-type natriuretic peptide (BNP), (B) N-terminal pro B-type natriuretic peptide (NT-proBNP), and (C) troponin I concentrations, as well as (D) QRS duration before and 6 months after the initiation of tafamidis in 6 patients who continued on tafamidis for more than 6 months. Median (interquartile rage) values for each of the parameters before and at 6 months are given at the top of each graph.